Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Lantheus Holdings Stock Won Big on Wednesday

The stock of radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) was a standout in the healthcare sector on Hump Day. The company saw its share price improve by almost 9% at market close, thanks...

LNTH : 89.29 (-2.89%)
Lantheus Holdings, Inc. Authorizes $250 Million Stock Repurchase Program to Enhance Shareholder Value

Lantheus Holdings announces a $250 million stock buyback program to enhance shareholder value while pursuing growth opportunities.Quiver AI SummaryLantheus Holdings, Inc. has announced a stock repurchase...

LNTH : 89.29 (-2.89%)
Lantheus Announces Share Repurchase Program

LNTH : 89.29 (-2.89%)
Lantheus to Present at the Jefferies London Healthcare Conference

LNTH : 89.29 (-2.89%)
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

LNTH : 89.29 (-2.89%)
Lantheus Holdings: Q3 Earnings Snapshot

Lantheus Holdings: Q3 Earnings Snapshot

LNTH : 89.29 (-2.89%)
Lantheus Reports Third Quarter 2024 Financial Results

LNTH : 89.29 (-2.89%)
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

LNTH : 89.29 (-2.89%)
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

LNTH : 89.29 (-2.89%)
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

ONCY : 0.8310 (-6.36%)
NVS : 97.11 (+0.35%)
LNTH : 89.29 (-2.89%)
STRO : 1.8800 (+3.30%)
ZYME : 14.14 (+4.12%)
ONC.TO : 1.19 (-9.16%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025?
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar